These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 10213312)
1. New insights into the interaction between the gp120 and the HIV receptor in human sperm (human.sperm/gp120/galactoglycerolipid/antigalactosylceramide/seminolip id/spermatogonia). Brogi A; Presentini R; Moretti E; Strazza M; Piomboni P; Costantino-Ceccarini E J Reprod Immunol; 1998 Dec; 41(1-2):213-31. PubMed ID: 10213312 [TBL] [Abstract][Full Text] [Related]
2. Interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with a galactoglycerolipid associated with human sperm. Brogi A; Presentini R; Solazzo D; Piomboni P; Costantino-Ceccarini E AIDS Res Hum Retroviruses; 1996 Apr; 12(6):483-9. PubMed ID: 8679303 [TBL] [Abstract][Full Text] [Related]
3. Human sperm and spermatogonia express a galactoglycerolipid which interacts with gp120. Brogi A; Presentini R; Piomboni P; Collodel G; Strazza M; Solazzo D; Costantino-Ceccarini E J Submicrosc Cytol Pathol; 1995 Oct; 27(4):565-71. PubMed ID: 7585449 [TBL] [Abstract][Full Text] [Related]
4. Glycolipids as potential binding sites for HIV: topology in the sperm plasma membrane in relation to the regulation of membrane fusion. Gadella BM; Hammache D; Piéroni G; Colenbrander B; van Golde LM; Fantini J J Reprod Immunol; 1998 Dec; 41(1-2):233-53. PubMed ID: 10213313 [TBL] [Abstract][Full Text] [Related]
5. Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon epithelial cells. Yahi N; Sabatier JM; Nickel P; Mabrouk K; Gonzalez-Scarano F; Fantini J J Biol Chem; 1994 Sep; 269(39):24349-53. PubMed ID: 7929093 [TBL] [Abstract][Full Text] [Related]
6. Identification of CD4-independent HIV receptors on spermatozoa. Bandivdekar AH; Velhal SM; Raghavan VP Am J Reprod Immunol; 2003 Oct; 50(4):322-7. PubMed ID: 14672335 [TBL] [Abstract][Full Text] [Related]
7. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Fantini J; Cook DG; Nathanson N; Spitalnik SL; Gonzalez-Scarano F Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2700-4. PubMed ID: 8464878 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of glycolipid analogues that disrupt binding of HIV-1 gp120 to galactosylceramide. Weber KT; Hammache D; Fantini J; Ganem B Bioorg Med Chem Lett; 2000 May; 10(10):1011-4. PubMed ID: 10843204 [TBL] [Abstract][Full Text] [Related]
9. CD4 independent binding of HIV gp120 to mannose receptor on human spermatozoa. Fanibunda SE; Velhal SM; Raghavan VP; Bandivdekar AH J Acquir Immune Defic Syndr; 2008 Aug; 48(4):389-97. PubMed ID: 18614929 [TBL] [Abstract][Full Text] [Related]
10. Characteristics of HIV-1 gp120 glycoprotein binding to glycolipids. McAlarney T; Apostolski S; Lederman S; Latov N J Neurosci Res; 1994 Mar; 37(4):453-60. PubMed ID: 8021969 [TBL] [Abstract][Full Text] [Related]
11. Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Bhat S; Spitalnik SL; Gonzalez-Scarano F; Silberberg DH Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7131-4. PubMed ID: 1871126 [TBL] [Abstract][Full Text] [Related]
12. Asymmetric synthesis of water-soluble analogues of galactosylceramide, an HIV-1 receptor: new tools to study virus-glycolipid interactions. Villard R; Hammache D; Delapierre G; Fotiadu F; Buono G; Fantini J Chembiochem; 2002 Jun; 3(6):517-25. PubMed ID: 12325007 [TBL] [Abstract][Full Text] [Related]
13. Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide. Long D; Berson JF; Cook DG; Doms RW J Virol; 1994 Sep; 68(9):5890-8. PubMed ID: 8057468 [TBL] [Abstract][Full Text] [Related]
14. Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop. Cook DG; Fantini J; Spitalnik SL; Gonzalez-Scarano F Virology; 1994 Jun; 201(2):206-14. PubMed ID: 8184533 [TBL] [Abstract][Full Text] [Related]
15. The gp120 glycoprotein of HIV-1 binds to sulfatide and to the myelin associated glycoprotein. van den Berg LH; Sadiq SA; Lederman S; Latov N J Neurosci Res; 1992 Dec; 33(4):513-8. PubMed ID: 1282933 [TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma decreases cell surface expression of galactosyl ceramide, the receptor for HIV-1 GP120 on human colonic epithelial cells. Yahi N; Spitalnik SL; Stefano KA; De Micco P; Gonzalez-Scarano F; Fantini J Virology; 1994 Nov; 204(2):550-7. PubMed ID: 7941321 [TBL] [Abstract][Full Text] [Related]
17. In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop. Andrianov AM; Kornoushenko YV; Kashyn IA; Kisel MA; Tuzikov AV J Biomol Struct Dyn; 2015; 33(5):1051-66. PubMed ID: 24942968 [TBL] [Abstract][Full Text] [Related]
18. HIV-1 envelope glycoprotein gp120 does not bind to galactosylceramide-expressing rat oligodendrocytes. Parmantier E; Monge M; Yagello M; Cabon F; Demerens C; Gluckman JC; Zalc B Virology; 1995 Feb; 206(2):1084-91. PubMed ID: 7856083 [TBL] [Abstract][Full Text] [Related]